URGN
UroGen Pharma Ltd.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
+16.31%
vs ±16.0% implied · ×1.02
shaded = implied · ▲▼ = realized
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RTW InvestmentsRTW | $167.2M | 10.61% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $117.8M | 7.47% | +12.51% | |
| 3 | Morgan StanleyMorgan Stanley | $94.8M | 6.02% | +0.64% | |
| 4 | Kynam Capital ManagementKynam | $89.6M | 5.68% | +8.31% | |
| 5 | Leucadia NationalLeucadia National | $80.9M | 5.14% | 0.00% | |
| 6 | SG Americas SecuritiesSG Americas Securities | $75.5M | 4.79% | +23.83% | |
| 7 | American Century CompaniesAmerican Century Companies | $62.0M | 3.94% | +2.94% | |
| 8 | Acorn Capital AdvisorsAcorn Capital | $61.6M | 3.91% | 0.00% | |
| 9 | Point72 Asset ManagementPoint72 | $56.1M | 3.56% | new | |
| 10 | Frontier Capital ManagementFrontier | $55.5M | 3.52% | +14.80% | |
| 11 | Opaleye ManagementOpaleye | $53.0M | 3.36% | +0.70% | |
| 12 | Silverarc Capital ManagementSilverarc | $47.9M | 3.04% | −13.38% | |
| 13 | Menora Mivtachim HoldingsMenora Mivtachim | $42.4M | 2.69% | 0.00% | |
| 14 | D. E. ShawD. E. Shaw | $42.2M | 2.68% | +11.99% | |
| 15 | State StreetState Streetindex-like | $36.9M | 2.34% | +14.74% | |
| 16 | MPM Oncology Impact ManagementMPM Oncology Impact | $34.3M | 2.18% | −1.10% | |
| 17 | Soleus Capital ManagementSoleus | $30.5M | 1.94% | +14.14% | |
| 18 | Goldman Sachs GroupGoldman Sachs | $30.2M | 1.91% | +36.98% | |
| 19 | Migdal Insurance & Financial HoldingsMigdal Insurance & Financial | $28.4M | 1.80% | 0.00% | |
| 20 | Orbimed AdvisorsOrbimed | $24.9M | 1.58% | −22.76% | |
| 21 | Geode Capital ManagementGeodeindex-like | $22.5M | 1.43% | +16.52% | |
| 22 | Woodline PartnersWoodline Partners | $18.4M | 1.17% | 0.00% | |
| 23 | Boxer Capital ManagementBoxer | $18.4M | 1.17% | 0.00% | |
| 24 | Bank of AmericaBank of America | $17.5M | 1.11% | +275.21% | |
| 25 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $16.8M | 1.07% | +11.48% |
190 managers report $1.6B of UroGen Pharma on form 13F for the quarter ended Jun 30 '26. 22 of them hold 80% of it; RTW is largest at 10.61%.
Expected move
Inputs8Q avg ±9.6%·×1.34·rich
straddle ±15.7%
spot 32.72exp Nov 20ATM strike 33ATM straddle 6.05IV 96%
UroGen Pharma Ltd.
32.70
−0.78 · −2.33%
post 32.70 0.00%